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A fiber-stable, repeatable and highly sensitive headspace solid-phase microextraction (HS-SPME) method was
developed for the analysis of methamphetamine (MA) and amphetamine (AM) in urine using gas
chromatography-mass spectrometry (GC-MS) in the selected ion monitoring mode. For sample preparation, the
test specimen was placed in a 7 ml vial along with the additives (KOH and NaCl) and the internal standards
(d8-MA and d8-AM), a glass insert containing heptafluorobutyric anhydride (HFBA) and heptafluorobutyric
chloride (HFBCl) as derivatizing reagents was inserted into the vial, the vial was then sealed tightly. A SPME
device with a 100 µm polydimethylsiloxane fiber was inserted into the vial and the fiber was exposed to the
headspace in the insert, then the vial was heated and stirred at 100 °C and 600 rpm for 20 min for
evaporation/adsorption/derivatization. The vaporized analytes (AM and MA) in the vial diffused into the glass
insert though the holes on the insert, they absorbed onto the fiber, and then interacted with the vapor of the
derivatizing reagent. Some of the analytes in the headspace of the glass insert may react with the vapor of the
derivatizing reagent first, and then adsorb onto the fiber. The needle was finally removed and inserted into the
injection port to desorb the analytes with the fiber exposed to the liner of the GC-MS system for analysis. By
combining HFBCl and HFBA as derivatizing reagents and placing them in an insert, the HS-SPME method
achieves high sensitivity for the analysis of AM and MA. Correlation coefficients derived from typical calibration
curves in the 1.0–1700 ng ml21 range are 0.998 for MA and 0.994 for AM. The limits of detection and the limits
of quantitation using a sample size of 1 ml are 0.3 and 1.0 ng ml21, respectively, for both MA and AM in urine
specimens. Because the water hydrolysis of derivatizing reagent is much faster than the acylation reaction of the
primary and secondary amines with the derivatizing reagent, the amphetamines cannot be acylated effectively over
heated aqueous solution, and therefore this study provides a new acylation design in moisture surroundings. The
proposed process also simplifies the procedure for urine sample preparation, and makes the automation of SPME
possible.
Introduction
Liquid–liquid extraction (LLE) and solid-phase extraction
(SPE) methods are widely used for the analysis of abused drugs
and their metabolites in biological specimens.1–4 These meth-
ods require organic solvents and are generally time consuming.
Solid-phase microextraction (SPME) is a simple, fast and
solventless approach, involving the partitioning of the analytes
between the fiber and the sample matrix, analytes are then
thermally desorbed from the fiber in the injection port of a gas
chromatograph (GC) for further analysis; thus, integrating
sample extraction, concentration and sample introduction into a
simplified process free from organic solvent. As the latest
development in sample preparation technologies, SPME has
also been applied to the analysis of drugs in forensic and clinical
laboratories.5–8
Recently, SPME was used for the determination of ampheta-
mines in bio-samples by liquid chromatography-mass spec-
trometry (LC-MS)9 and GC-MS.10,11 For headspace (HS)
SPME, derivatizing amphetamines on the fiber to increase its
detection sensitivity is essential. An on-column derivatization
procedure12,13 was also reported, in which the derivatizing
reagent was injected into the GC injection port immediately
prior to the insertion of the analyte-carrying fiber. This method,
however, may cause unnecessary contamination to the GC-MS
system, resulting in shortened column life and additional
maintenance requirements. An on-fiber derivatization approach
(on-fiber SPME)14 has also been developed, in which the
adsorption and the derivatization processes were conducted in
two separate vials. Further development involved the addition
of heptafluorobutyric bromide into blood samples for deriva-
tization prior to the SPME step.15 This latest approach greatly
simplified the adsorption and derivatization procedures; how-
ever, low recovery of methamphetamine (MA) and ampheta-
mine (AM) (0.5–1.0%) was experienced.
This current study explores an approach in which the
extraction and the derivatization steps are allowed to occur
simultaneously at the headspace with a derivatizing-reagent-
containing insert placed in the sample vial; thus being isolated
from the sample matrix. This approach (HS-SPME) generated
excellent recovery and assay linearity, while lengthening the
life of the fiber and the cleaning interval of the GC-MS
system.
Experimental
Reagents and materials
Methamphetamine-d8 (d8-MA) and amphetamine-d8 (d8-AM)
in methanol, supplied by Cerilliant (Austin, TX, USA), are
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diluted to 10000 ng ml21 in ethanol and the diluted solutions are
used as internal standards. An MA- and AM-containing urine
standard (MA = 1696 ng ml21 and AM = 1659 ng ml21) was
purchased from Bio-Rad (Irvine, CA, USA). These solutions
were stored at 4 °C in a refrigerator during the period of the
study. The derivatizing reagents, heptafluorobutyric chloride
(HFBCl) and heptafluorobutyric anhydride (HFBA) were
purchased from ACROS (Geel, Belgium) and Supelco (Belle-
fonte, PA, USA), respectively.
The adapted SPME device, including the extraction fiber
coated with 100 µm polydimethylsiloxane, was purchased from
Supelco. Drug-free urine collected from adult males was used to
dilute the drug-containing standards to the desired concentra-
tions. Extraction vials (7 ml) were obtained from Supelco, while
the glass inserts used for holding the derivatizing reagent were
purchased from a local supplier.
Sample preparation: the analyte
evaporation/extraction/derivatization process
The test specimen (1.0 ml urine) was placed in a 7 ml vial with
the additives (1 ml 2 mol l21 KOH, and 0.5 g NaCl), the internal
standards (100 µl d8-MA and d8-AM) and a magnetic rotator
bar, then a glass insert containing 40 µl of HFBCl–HFBA (8 +
2 v/v) as derivatizing reagent was inserted (shown in Fig. 1).
The vial was then sealed tightly with a screw cap using a
silicone septum liner. The needle of the SPME device was
inserted through the septum of the vial and the extraction fiber
was exposed to the headspace in the glass insert. The vial was
then heated in an aluminium block on a digital hot plate/
magnetic stirrer (Mirak, Thermolyne, Dubuque, IA, USA) and
stirred at 600 rpm for 20 min. The analytes (vapor of AM and
MA) in the headspace of the vial diffused into the glass insert
through the holes (2 mm diameter) on the insert, absorbed onto
the fiber, and subsequently interacted with the vapor of the
derivatizing reagent. Some of the analytes in the headspace of
the glass insert may react with the vapor of the derivatizing
reagent first, and then adsorb onto the fiber. The needle was
finally removed and inserted into the injection port (260 °C) to
desorb the analytes for 10 min with the fiber exposed to the liner
of the GC-MS system.
Optimal sample preparation conditions were determined by
first evaluating four additive solutions (1 ml 10 mol l21 KOH;
1 ml 1 mol l21 KOH with 0.5 g NaCl; 1 ml 1 mol l21 K2CO3
with 0.5 g NaCl; and 1 ml 1 mol l21 tris-(hydroxymethyl)ami-
nomethane with 0.5 g NaCl) using heating temperature at 100
°C and 20 min adsorption time. The optimal alkali solution was
then adapted to determine the optimal heating temperature and
adsorption time. Temperatures studied were 70, 80, 90, 100, and
110 °C, while the five different reaction times studied were 10,
20, 30, 40, and 60 min.
Gas chromatography-mass spectrometry
An Agilent 5973N GC-MS (Wilmington, DE, USA), equipped
with a 30 m 3 0.25 mm (id) fused silica capillary column
(Agilent HP-5 ms; 0.25 µm film thickness), was used for the
Fig. 2 Mass chromatograms of: (a) HFB-d8-AM, (b) HFB-AM, (c) HFB-d8-MA, and (d) HFB-MA.
Fig. 1 Extraction and derivatization apparatus.
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study. The GC operating conditions are as the following: initial
temperature, 90 °C; hold, 3 min; ramp, 20 °C min21; final
temperature, 280 °C; hold, 3 min; total run time, 15.5 min;
injection port temperature, 260 °C; interface temperature, 230
°C; carrier gas, helium; carrier gas flow rate,1 ml min21;
injection mode, splitless; quantitation ions used for selected ion
monitoring (SIM), m/z 240 for AM, 254 for MA, 243 for d8-AM
and 261 for d8-MA (all as HFB derivatives).
Absolute recovery, reproducibility, calibration curve, and
sensitivity
1.0 ml urine standards containing 500 ng and 50 ng of AM and
MA were prepared and used for extraction recovery and
reproducibility studies. Absolute recovery data were calculated
by comparing the peak area of the standards processed through
the entire procedure against those derived from unextracted
standard solutions in methanol. Six replicates were used for
inter- and intra-day reproducibility studies. To determine the
linear range of the protocol, AM- and MA-containing urine
standards were prepared over a 1–1700 ng ml21 concentration
range. Calibration curves were established by plotting the AM/
d8-AM or MA/d8-MA peak area ratios against the concentra-
tions of AM and MA. The limit of detection (LOD) and limit of
quantitation (LOQ) for both AM and MA were determined
based on the signal-to-noise ratio of five blanks and were set at
3 and 10, respectively.
Results and discussion
Typical ion chromatograms derived from SIM GC-MS analysis
of the analyte-loaded fibers are shown in Fig. 2. With the
derivatization and adsorption taking place in the headspace, the
proposed HS-SPME approach appears to generate much cleaner
chromatograms than those derived from on-fiber SPME, SPE
and LLE methods.
Additives, heating temperature, and adsorption time
The effect of additives on the amount of AM and MA recovered
are shown in Fig. 3. Among the four additives studied, the 1 mol
l21 KOH and NaCl combination provided the highest abun-
dance, suggesting the significance of the matrix pH and ionic
strength.
Fiber extraction is theoretically an exothermic process
resulting in lower analyte recovery at a higher temperature.
However, an elevated sampling temperature improves the mass
transfer of AM and MA from the matrix to the headspace. Thus,
the optimal temperature is determined empirically along with
the duration of the adsorption time.
The data shown in Fig. 4 and Fig. 5 indicate: (a) for AM,
adsorption appears to reach a maximum at approximately 20
min at 100 and 110 °C, while the maximal amount adsorbed
occurs at 40 min when the adsorption is conducted at 80 and 90
°C; (b) for MA, the equilibrium was reached at approximately
20 min regardless of the temperature tested; and (c) the amount
of AM and MA adsorbed at 100 and 110 °C are more than that
at 80 and 90 °C. Based on these data, a combination of a 20 min
absorption time and an adsorption temperature of 100 °C was
considered optimal and was adapted for the remainder of this
study.
Absolute recovery and reproducibility
Urine samples containing two levels (50 and 500 ng ml21) of
AM and MA were used to study the absolute recovery of these
two compounds under the established protocol. The data shown
in Table 1 indicate slightly better recovery for MA over AM.
Absolute recoveries of AM and MA in this study were higher
than those previously reported.15 Massive water vapor in the
headspace may help release the acid resulting from the
derivatization reaction; thus, improving the yields of the
derivatized products, HFB-AM and HFB-MA. The relative
standard deviations for intra-day and inter-day analyses at a
Fig. 3 The effect of additives on the adsorption of AM and MA.
Table 1 Absolute recovery and relative standard deviation of intra-day and inter-day analysis of AM and MA
Absolute recovery(%) Relative standard deviation
Concentration/
ng ml21 Compound Intra-day (n = 6) Inter-day (n = 6) Intra-day (n = 6) Inter-day (n = 6)
50 Amphetamine 7.87 6.82 4.55 3.76
Methamphetamine 8.61 7.11 2.27 2.44
500 Amphetamine 10.39 9.14 2.29 2.38
Methamphetamine 11.56 9.77 1.56 2.83
Fig. 4 The effect of heating temperatures and adsorption–derivatization
time of AM.
Fig. 5 The effect of heating temperatures and adsorption–derivatization
time of MA.
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concentration of 50 ng ml21 are 2.27, 4.55% (MA) and 2.44,
3.76% (AM), respectively.
Linearity, limit of detection and limit of quantitation
Typical correlation coefficients of the calibration curves
established in the 1.0–1700 ng ml21 range are 0.994 for AM and
0.998 for MA (Table 2), while the LODs and LOQs in urine
were 0.3 and 1.0 ng ml21. The combined use of HFBCl and
HFBA, and placing them in an insert (instead of mixing them in
the sample matrix), produced better results than HFBA alone
and gave a better detection limit than those previously reported.
A comparison of the detection limits with published results9–15
is listed in Table 3. The detection limits of this study are lower
than all the values reported in the literature.
Conclusions
The proposed sample preparation procedure is much simpler
than the conventional LLE, and SPE approaches and does not
require the use of organic solvent. By combining HFBCl and
HFBA as derivatizing reagents and placing them in an insert
(instead of mixing them in the sample matrix), the HS-SPME
method achieves high sensitivity for the analysis of AM and
MA in urine specimens. After 20 times fiber usage, the
abundance of GC-MS for 500 ng ml21 AM and 500 ng ml21
MA are decreased by 27% and 25% of the abundance of the first
injection, the fiber is still transparent and flexible, and permits
reuse due to the usage of internal standards.
Because the water hydrolysis of the derivatizing reagent is
much faster than the acylation reaction of the primary and
secondary amines with the derivatizing reagent, the ampheta-
mines cannot be acylated effectively over heated aqueous
solution, and therefore this study provides a new acylation
design in a moist environment. The proposed process also
simplified the procedures of urine sample preparation, and
makes the automation of SPME possible. Finally, the detection
limits of this study are lower than those reported in the
literature.
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Table 2 Linear regression equations, correlation coefficients, and limits of detection (LOD) and quantitation (LOQ)
Compound Regression equationa
Correlation
coefficient (r2) LOD/ng ml21 LOQ/ng ml21
Amphetamine y = 0.0019x 2 0.055 0.994 0.3 1.0
Methamphetamine y = 0.0021x 2 0.012 0.998 0.3 1.0
a x is the amount of analytes (ng ml21) and y is the peak area ratio.
Table 3 Sensitivity comparison with refs. 9–15
LOD/ng ml21 LOQ/ng ml21
AM MA AM MA Matrix SPME method Derivatizing reagent
Chromatography
detector
This study 0.3 0.3 1 1 Urine Headspace HFBCl + HFBA SIM, GC-MS
Ref. 9 79 54 — — Urine In-tube No derivatization SIM, LC-MS
Ref. 10 — — — — Urine Headspace No derivatization Full scan, GC-MS
Ref. 11 15 5 — — Urine In solution Propylchloroformate Full scan, GC-MS
Ref. 12 10 10 — — Blood Headspace HFBA SIM, GC-MS
Ref. 13 10 5 — — Blood Headspace HFBA SIM, GC-MS
Ref. 14 3 3 10 10 Urine Headspace TFAa SIM, GC-MS
Ref. 15 0.5 0.5 — — Blood Headspace PFBBrb SIM, GC-MS
a Trifluoroacetic anhydride. b Pentafluorobenzyl bromide.
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